Panacea Life Sciences Holdings, Inc. (PLSH)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Pharmaceuticals	2.38M	1.63M	2.06M	9.02M	2.20M
Pharmaceuticals Growth	46.59%	-21.01%	-77.16%	310.19%	-
Total	2.38M	1.63M	2.06M	9.02M	2.20M
Total Growth	46.59%	-21.01%	-77.16%	310.19%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
United States	2.38M	1.63M	2.06M	9.02M	2.20M
United States Growth	46.59%	-21.01%	-77.16%	310.19%	-
Total	2.38M	1.63M	2.06M	9.02M	2.20M
Total Growth	46.59%	-21.01%	-77.16%	310.19%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 3, 2026

Data Sources Report a data error